RESEARCH - Risk of malignancy in children may be increased by TNF blockers

[Guest guest]

The Risk Of Malignancy In Children May Be Increased By TNF Blockers

MedicalNewsToday.com

Article Date: 31 Jul 2010 - 0:00 PDT

The Food and Drug Administration (FDA) received reports of

malignancies in children using tumor necrosis factor a (TNF) blockers,

raising concerns of an associated risk and prompting an investigation.

Researchers from the FDA set out to identify all reports of malignancy

in children using infliximab, etanercept, and adalimumab and their

report is published in the August issue of Arthritis & Rheumatism, a

journal of the American College of Rheumatology.

*****************************************

Read the full article here:

http://www.medicalnewstoday.com/articles/196370.php

Not an MD